Individuals with Insulin Resistance: Even without a formal diabetes diagnosis, GLP-1 medications might be considered in cases of significant insulin resistance
Authors' contributions GG carried out GP method optimization and evaluation of GP activity in pregnancy
Now used for obesity treatment without diabetes, GLP-1 receptor agonists are available in various forms, including injectable options like exenatide extended-release
The look of dark spots, acne marks and uneven tone
The GLP-1 based therapies were also not associated with a significant change in adiponectin levels in the blood with a mean difference in percent change from baseline between GLP-1 based therapies and controls of 53.63 [133.86, 26.61] % (P = 0.19
As a GLP-1 receptor agonist, it stimulates the pancreas to produce insulin when blood sugar is high and inhibits glucose release from the liver when levels are low helping maintain stable blood sugar levels essential for managing diabetes
